Eric Adjei Boakye1,2, Maggie Wang3, Arun Sharma4, Wiley D Jenkins5,6, Nosayaba Osazuwa-Peters7,8, Betty Chen4, Minjee Lee5,6, Mario Schootman9. 1. Department of Population Science and Policy, Southern Illinois University School of Medicine, 201 E. Madison Street, P. O. Box 19664, Springfield, IL, 62794, USA. eadjeiboakye49@siumed.edu. 2. Simmons Cancer Institute, Southern Illinois University School of Medicine, Springfield, IL, USA. eadjeiboakye49@siumed.edu. 3. Saint Louis University School of Medicine, Saint Louis, MO, USA. 4. Department of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA. 5. Department of Population Science and Policy, Southern Illinois University School of Medicine, 201 E. Madison Street, P. O. Box 19664, Springfield, IL, 62794, USA. 6. Simmons Cancer Institute, Southern Illinois University School of Medicine, Springfield, IL, USA. 7. Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine, St. Louis, MO, USA. 8. Saint Louis University Cancer Center, Saint Louis, MO, USA. 9. Department of Clinical Analytics and Insights, Center for Clinical Excellence, SSM Health, Saint Louis, MO, USA.
Abstract
PURPOSE: As the number of cancer survivors in the United States increases, quantifying the risks and burden of second primary cancers (SPCs) among cancer survivors will help develop long-term prevention and surveillance strategies. We describe the risk of developing a SPC among survivors of 10 cancer sites with the highest survival rates in the United States. METHODS: Adult patients diagnosed with an index smoking-related (urinary bladder, kidney and renal pelvis, uterine cervix, oral cavity and pharynx, and colon and rectum) and index non-smoking-related (prostate, thyroid, breast, corpus and uterus, and non-Hodgkin lymphoma) cancers were identified from Surveillance, Epidemiology, and End Results (2000-2015). SPC risks were quantified using standardized incidence ratios (SIRs) and excess absolute risks (EARs) per 10,000 person-years at risk (PYR). RESULTS: A cohort of 2,903,241 patients was identified and 259,685 (8.9%) developed SPC (7.6% of women and 10.3% of men). All index cancer sites (except prostate) were associated with a significant increase in SPC risk for women and men. Patients diagnosed with smoking-related index cancers (SIR range 1.20-2.16 for women and 1.12-1.91 for men) had a higher increased risk of SPC than patients with non-smoking-related index cancers (SIR range 1.08-1.39 for women and 1.23-1.38 for men) relative to the general population. CONCLUSION: We found that 1-in-11 cancer survivors developed a SPC. Given the increasing number of cancer survivors and the importance of SPC as a cause of cancer death, there is a need for increased screening for and prevention of SPC.
PURPOSE: As the number of cancer survivors in the United States increases, quantifying the risks and burden of second primary cancers (SPCs) among cancer survivors will help develop long-term prevention and surveillance strategies. We describe the risk of developing a SPC among survivors of 10 cancer sites with the highest survival rates in the United States. METHODS: Adult patients diagnosed with an index smoking-related (urinary bladder, kidney and renal pelvis, uterine cervix, oral cavity and pharynx, and colon and rectum) and index non-smoking-related (prostate, thyroid, breast, corpus and uterus, and non-Hodgkin lymphoma) cancers were identified from Surveillance, Epidemiology, and End Results (2000-2015). SPC risks were quantified using standardized incidence ratios (SIRs) and excess absolute risks (EARs) per 10,000 person-years at risk (PYR). RESULTS: A cohort of 2,903,241 patients was identified and 259,685 (8.9%) developed SPC (7.6% of women and 10.3% of men). All index cancer sites (except prostate) were associated with a significant increase in SPC risk for women and men. Patients diagnosed with smoking-related index cancers (SIR range 1.20-2.16 for women and 1.12-1.91 for men) had a higher increased risk of SPC than patients with non-smoking-related index cancers (SIR range 1.08-1.39 for women and 1.23-1.38 for men) relative to the general population. CONCLUSION: We found that 1-in-11 cancer survivors developed a SPC. Given the increasing number of cancer survivors and the importance of SPC as a cause of cancer death, there is a need for increased screening for and prevention of SPC.
Entities:
Keywords:
Cancer survivors; Malignant neoplasm; Second primary cancer; Smoking-associated cancers; Surveillance Epidemiology and End Results (SEER) program
Authors: Eric Adjei Boakye; Paula Buchanan; Leslie Hinyard; Katie Stamatakis; Nosayaba Osazuwa-Peters; Matthew C Simpson; Mario Schootman; Jay F Piccirillo Journal: Laryngoscope Date: 2018-12-24 Impact factor: 3.325
Authors: Eric Adjei Boakye; Paula Buchanan; Leslie Hinyard; Nosayaba Osazuwa-Peters; Matthew C Simpson; Mario Schootman; Jay F Piccirillo Journal: Int J Cancer Date: 2019-01-24 Impact factor: 7.396
Authors: Samuel J Gan; Kristina R Dahlstrom; Brandon W Peck; Wes Caywood; Guojun Li; Qingyi Wei; Mark E Zafereo; Erich M Sturgis Journal: Cancer Date: 2013-04-19 Impact factor: 6.860
Authors: P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton Journal: Nat Rev Cancer Date: 2004-03 Impact factor: 60.716
Authors: Nicholas Donin; Christopher Filson; Alexandra Drakaki; Hung-Jui Tan; Alex Castillo; Lorna Kwan; Mark Litwin; Karim Chamie Journal: Cancer Date: 2016-07-05 Impact factor: 6.860
Authors: Patricia Fitzpatrick; Nancy Bhardwaj; Ailsa Lyons; Kirsten Doherty; Kate Frazer; Amanda McCann; Vikram Niranjan; Shiraz Syed; Patricia Fox Journal: Int J Environ Res Public Health Date: 2022-02-18 Impact factor: 3.390
Authors: Logan Corey; Julie Ruterbusch; Ron Shore; Martins Ayoola-Adeola; Michael Baracy; Alex Vezina; Ira Winer Journal: Front Oncol Date: 2022-03-23 Impact factor: 6.244